GlaxoSmithkline Consumer Healthcare rose 2.2% to Rs 7,230 at 09:35 IST on BSE after net profit rose 43.18% to Rs 275.49 crore on 16.41% rise in total income to Rs 1361 crore in Q2 September 2018 over Q2 September 2017.
The result was announced after market hours yesterday, 1 November 2018.Meanwhile, the S&P BSE Sensex was up 412.78 points, or 1.2% to 34,844.75
On the BSE, 548 shares were traded in the counter so far compared with average daily volumes of 504 shares in the past two weeks. The stock had hit a high of Rs 7,346.45 and a low of Rs 7,175.90 so far during the day.
GlaxoSmithkline Consumer Healthcare Consumer Healthcare is the category leader in Indian health food drinks industry.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app